Walleye Capital’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$369K Buy
+5,100
New +$395K ﹤0.01% 4336
2026
Q1
– Sell
-7,500
Closed -$975K – 5050
2025
Q4
$975K Buy
7,500
+2,600
+53% +$357K ﹤0.01% 2452
2025
Q3
$528K Buy
4,900
+4,700
+2,350% +$512K ﹤0.01% 2562
2025
Q2
$18.5K Sell
200
-2,400
-92% -$188K ﹤0.01% 4244
2025
Q1
$230K Buy
+2,600
New +$226K ﹤0.01% 3165

Other funds holding WGS

Walleye Capital's WGS Position: Q3 2026 in Review

Walleye Capital reduced its GeneDx Holdings (WGS) stake by 78% in Q3 2026, selling an estimated $4.1M and leaving 15,005 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

Walleye Capital first reported a position in WGS in Q4 2020 and has held it in 6 quarters since. The position peaked at $4.66M in Q2 2026. 218 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Walleye Capital held 15,005 shares of GeneDx Holdings worth $1.08M as of Q3 2026.
  • Walleye Capital sold 52,895 GeneDx Holdings shares in Q3 2026, an estimated $4.1M.
  • GeneDx Holdings made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3394 holding.
  • Walleye Capital first reported a position in GeneDx Holdings in Q4 2020 and has held it in 6 quarters since.
  • Walleye Capital's GeneDx Holdings position peaked at $4.66M in Q2 2026.
  • 218 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.